Description
The HOYA iSert PY-60AD is a sophisticated intraocular lens (IOL) designed to enhance visual outcomes for patients undergoing cataract surgery. This preloaded, aspheric, 3-piece lens is engineered for primary implantation in the capsular bag, providing effective visual correction of aphakia in adult patients post-cataract removal.
Key Features
- Material Composition: The optic is crafted from hydrophobic acrylic, while the haptics are made from blue PMMA, ensuring durability and stability within the eye.
- Design: Its aspheric, aberration-correcting optic design includes a sharp edge to minimize posterior capsule opacification (PCO), enhancing long-term visual clarity.
- Haptic Configuration: Features a modified C-loop with 5° angulation for optimal positioning.
Specifications
- Optic Diameter: 6.0 mm
- Overall Length: 12.5 mm
- Power Range: Available from +6.00 to +30.00 diopters in 0.50 D increments, accommodating a wide range of visual needs.
- Filters: Equipped with UV and blue light filters to protect the eye from harmful light exposure.
Injector System
The lens is delivered through the fully preloaded iSert injector system, a single-use, disposable device that enhances surgical efficiency. This system allows for delivery through a 2.4 mm incision, streamlining the surgical process and reducing the risk of cross-contamination. The front injector tip has an outer diameter of 1.89 mm, facilitating precise placement.
Benefits
- Surgical Efficiency: The preloaded system reduces staff workload by eliminating the need for cleaning and sterilization of reusable injectors.
- Optical Performance: The sharp optic edge and aspheric design help reduce the risk of PCO, contributing to clearer vision post-surgery.
Longevity and Clinical Experience
With an expected lifetime of 20 years, the HOYA iSert PY-60AD offers long-term reliability. Since its launch in 2007, over 10 million IOLs have been implanted worldwide, reflecting its trusted performance in clinical settings.
Considerations
While there are no known contraindications for adults, potential adverse events such as wound leak, dry eye syndrome, and changes in intraocular pressure should be considered. Surgeons are advised to evaluate individual patient conditions to ensure optimal outcomes.
